EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

A novel nanomedicine integrating ferroptosis and photothermal therapy, well-suitable for PD-L1-mediated immune checkpoint blockade

Yujun Bao, Guanghao Li, Siqi Li, Haishui Zhou, Ziqing Yang, Zhiqiang Wang, Rui Yan, Changhong Guo, Yingxue Jin

Materials Today Bio · 2024-12 · 29 · 101346

DOI: 10.1016/j.mtbio.2024.101346 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Materials Today Bio, 2024-12. Verfasst von Yujun Bao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Cytogenetics and Genetic Breeding of Heilongjiang Province, College of Life Science and Technology, Harbin Normal Univers…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy based on immune checkpoint blockade has emerged as a promising treatment strategy; however, the therapeutic efficacy is limited by the immunosuppressive microenvironment. Here, we developed a novel immune-activated nanoparticle (Fc-SS-Fe/Cu) to address the issue of insufficient immune infiltration. Specifically, the structure of Fc-SS-Fe/Cu collapsed in response to the tumor microenvironment, the ferrocene and disulfide bonds and the released Fe/Cu ions can effectively generate ·OH and deplete GSH to increase oxidative stress, thereby inducing ferroptosis. Withal, the positive feedback mechanisms of "laser-triggered mild-temperature photothermal therapy (PTT), PTT accelerated ferroptosis and LPO accumulation, LPO mediated HSPs down-regulated to promote PTT," effectively triggers immunogenic cell death (ICD) in tumor cells, significantly enhancing their immunogenicity. Moreover, the O2-generating ability induced by Fc-SS-Fe/Cu could reverse the hypoxic tumor microenvironment, and importantly, the expression of PD-L1 on tumor cell surfaces could be effectively downregulated by inhibiting the HIF-1α pathways, thereby augmenting the effect of anti-PD-L1 (αPD-L1) therapy. Therefore, this study provides valuable strategies into enhancing PD-L1-mediated ICB therapy.

Schlagwörter

Stichwörter der Autor:innen

AntitumorFerroptosisImmune checkpoint blockadePD-L1Photothermal therapy

Autor:innen und Institutionen

  • Key Laboratory of Molecular Cytogenetics and Genetic Breeding of Heilongjiang Province, College of Life Science and Technology, Harbin Normal University, Harbin, 150025, China.
  • Key Laboratory for Photonic and Electronic Bandgap Materials, Ministry of Education, College of Chemistry & Chemical Engineering, Harbin Normal University, Harbin, 150025, China.
  • School of Basic Medical Sciences, Shandong University, Jinan, 250012, China.

Zitieren

APA

Bao, Y., Li, G., Li, S., Zhou, H., Yang, Z., Wang, Z., Yan, R., Guo, C., & Jin, Y. (2024). A novel nanomedicine integrating ferroptosis and photothermal therapy, well-suitable for PD-L1-mediated immune checkpoint blockade. Materials Today Bio, 29, 101346. https://doi.org/10.1016/j.mtbio.2024.101346

Vancouver

Bao Y, Li G, Li S, Zhou H, Yang Z, Wang Z, et al. A novel nanomedicine integrating ferroptosis and photothermal therapy, well-suitable for PD-L1-mediated immune checkpoint blockade. Materials Today Bio. 2024;29:101346. doi:10.1016/j.mtbio.2024.101346

BibTeX
@article{Bao2024,
  author = {Bao, Yujun and Li, Guanghao and Li, Siqi and Zhou, Haishui and Yang, Ziqing and Wang, Zhiqiang and Yan, Rui and Guo, Changhong and Jin, Yingxue},
  title = {A novel nanomedicine integrating ferroptosis and photothermal therapy, well-suitable for PD-L1-mediated immune checkpoint blockade},
  journal = {Materials Today Bio},
  year = {2024},
  volume = {29},
  pages = {101346},
  doi = {10.1016/j.mtbio.2024.101346}
}
Kostenlos starten →